Povidone iodine/dexamethasone otic suspension

Drug Profile

Povidone iodine/dexamethasone otic suspension

Alternative Names: FST-201

Latest Information Update: 12 May 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Foresight Biotherapeutics
  • Class Anti-inflammatories; Antiseptics; Disinfectants
  • Mechanism of Action Glucocorticoid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • No development reported Otitis externa

Most Recent Events

  • 12 May 2015 No development reported - Phase-III for Otitis externa in American Samoa (Topical)
  • 12 May 2015 No development reported - Phase-III for Otitis externa in USA (Topical)
  • 27 Jul 2011 Phase-III development is ongoing in USA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top